brentuximab,doxorubicin hydrochloride,dacarbazine,filgrastim,pegfilgrastim,nivolumab,vinblastine sulfate
seagen,amgen,bms
['hodgkin', 'lymphoma', 'nivo', 'swog 1826']
swog 1826 w/ dr. alex herrera: nivo-avd vs bv-avd for patients with advanced stage classical hodgkin lymphoma: 1-year pfs 94 vs 86% hr 0.48 (p=0.0005). os not yet mature. #asco23 
Medical oncologist: GI cancers & cancer of unknown primary + high quality & value-based cancer care delivery. @UTexasValue MSHCT student. Tweets mine.